Clinically Relevant Measures of Fit? A Note of Caution

Interpreting Incremental Value of Markers Added to Risk Prediction Models

(2012) Michael J. Pencina et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Performance of reclassification statistics in comparing risk prediction models

(2011) Nancy R. Cook et al.   BIOMETRICAL JOURNAL

Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2

(2011) N. C. Munshi et al.   BLOOD

One statistical test is sufficient for assessing new predictive markers

(2011) Andrew J Vickers et al.   BMC Medical Research Methodology

Use of risk stratification to guide ambulatory management of neutropenic fever

(2011) L. J. Worth et al.   INTERNAL MEDICINE JOURNAL

Commentary: Reporting standards are needed for evaluations of risk reclassification

(2011) M. S. Pepe et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Comments on ‘Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers’ by M. J. Pencina, R. B. D'Agostino, Sr. and E. W. Steyerberg

(2011) Nancy R. Cook et al.   STATISTICS IN MEDICINE

Assessment of Clinical Validity of a Breast Cancer Risk Model Combining Genetic and Clinical Information

(2010) M. E. Mealiffe et al.   JNCI-Journal of the National Cancer Institute

Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers

(2010) Michael J. Pencina et al.   STATISTICS IN MEDICINE

American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction

(2009) Kala Visvanathan et al.   JOURNAL OF CLINICAL ONCOLOGY